SEC Form D · filed April 9, 2020
iTeos Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (16)
David Hallal · New Brighton, MNDirectorJonathan Skipper · Cambridge, MADirectorTim Van Hauwermeiren · Cambridge, MADirectorChris Buyse · Cambridge, MADirectorPriyanka Belawat · Cambridge, MADirectorDavid Hallal · New Brighton, MNDirectorDetlev Biniszkiewicz · Cambridge, MADirectorChris Buyse · Cambridge, MADirectorPriyanka Belawat · Cambridge, MADirectorMichel Detheux · Cambridge, MAExec · DirectorDetlev Biniszkiewicz · Cambridge, MADirectorAnsbert Gadicke · CAMBRIDGE, MADirectorJonathan Skipper · Cambridge, MADirectorAnsbert Gadicke · New Brighton, MNDirectorTim Van Hauwermeiren · Cambridge, MADirectorMichel Detheux · Cambridge, MAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗